Performance Stability of Silicone Oxide–Coated Plastic Parenteral Vials

Reference

1. 1.↵
   1. Walther M.,
   2. Rupertus V.,
   3. Seeman C.,
   4. Brecht J.,
   5. Hormes R.,
   6. Swift R. W.

   Pharmaceutical Vials with Extremely High Chemical Inertness. PDA J. Pharm. Sci. Technol. 2002, 56 (3), 124–129.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Schaut R. A.,
   2. Peanasky J. S.,
   3. DeMartino S. E.,
   4. Schiefelbein S. L.

   A New Glass Option for Parenteral Packaging. PDA J. Pharm. Sci. Technol. 2014, 68 (5), 527–534.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Ennis R. D.,
   2. Pritchard R.,
   3. Nakamura C.,
   4. Coulon M.,
   5. Yang T.,
   6. Visor G. C.,
   7. Lee W. A.

   Glass Vials for Small Volume Parenterals: Influence of Drug and Manufacturing Processes on Glass Delamination. Pharm. Dev. Technol. 2001, 6 (3), 393–405.

   OpenUrlPubMed
4. 4.↵
   1. Weikart C.,
   2. Langer R.,
   3. Klibanov A.

   Novel Primary Containers for Parenteral Drugs. PDA/FDA Glass Quality Conference, Washington, DC, June 4–5, 2012.
5. 5.↵
   1. Kinney S.,
   2. Weikart C.

   Novel Primary Containers for Parenteral Drugs. The Universe of Prefilled Syringes and Injection Devices, Las Vegas, NV, October 15–17, 2012.
6. 6.↵
   1. Sagona P.,
   2. Romero R.,
   3. Breeland A.

   A Novel Approach to Mitigating Oxygen Permeation in Pre-filled Syringes. Drug Del. Devel. 2014, 14 (7), 36–41.

   OpenUrl
7. 7.↵
   1. Yasuda H.

   Plasma Polymerization; Academic Press: Orlando, FL., 1985.
8. 8.↵
   1. Chatham H.

   Oxygen Diffusion Barrier Properties of Transparent Oxide Coatings on Polymeric Substrates. Surf. & Coat. Technol. 1996, 78 (1–3), 1–9.

   OpenUrlCrossRef
9. 9.↵
   1. Ceiler M. F.,
   2. Kohl P. A.,
   3. Bidstrup S. A.

   Plasma-Enhanced Chemical Vapor Deposition of Silicon Oxide Deposited at Low Temperatures. J. Electrochem. Soc. 1995, 142 (6), 2067–2071.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Swift R.

    Glass Containers for Parenteral Products. In Pharmaceutical Dosage Forms: Parenteral Medications, 3rd ed.; Informa Healthcare: New York, 2010; Vol. 1.
11. 11.↵
    1. Weikart C.,
    2. Saaler-Reinhardt S.

    Glass Like Inner Barrier Coating Prevents Contamination of Drug Products with Potential Impurities From Primary Containers Composed of COP, A Case Study. Extractables & Leachables Europe, November 9, 2016.
12. 12.↵
    1. Kinney S.,
    2. Turney K.,
    3. Sagona P.

    Part I of II: Improved Parenteral Containers through Plasma Deposition of High Purity Glass. ONdrug Delivery Magazine 2013, 45, 46–49.

    OpenUrl
13. 13.↵
    1. Kinney S.,
    2. Weikart C.,
    3. Sagona P.

    Part II of II: Improved Parenteral Containers through Plasma Deposition of High Purity Glass. ONdrug Delivery Magazine 2014, 47, 18–22.

    OpenUrl